HMMR and ovarian cancer: Upregulation of VCAN in CAFs enhanced ovarian cancer cell motility and invasion potential by activating the NF-κB signaling pathway and upregulated expression of CD44, MMP9 and the hyaluronan mediated motility receptor (37).